Development of the Blood-Brain Interface

2007 ◽  
pp. 9-39 ◽  
Author(s):  
Britta Engelhardt
Keyword(s):  
Biomolecules ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 359
Author(s):  
Maximilian Lenz ◽  
Amelie Eichler ◽  
Andreas Vlachos

Inflammation of the central nervous system can be triggered by endogenous and exogenous stimuli such as local or systemic infection, trauma, and stroke. In addition to neurodegeneration and cell death, alterations in physiological brain functions are often associated with neuroinflammation. Robust experimental evidence has demonstrated that inflammatory cytokines affect the ability of neurons to express plasticity. It has been well-established that inflammation-associated alterations in synaptic plasticity contribute to the development of neuropsychiatric symptoms. Nevertheless, diagnostic approaches and interventional strategies to restore inflammatory deficits in synaptic plasticity are limited. Here, we review recent findings on inflammation-associated alterations in synaptic plasticity and the potential role of the blood–brain interface, i.e., the blood–brain barrier, in modulating synaptic plasticity. Based on recent findings indicating that brain stimulation promotes plasticity and modulates vascular function, we argue that clinically employed non-invasive brain stimulation techniques, such as transcranial magnetic stimulation, could be used for monitoring and modulating inflammation-induced alterations in synaptic plasticity.


2021 ◽  
Vol 12 ◽  
Author(s):  
Fabien Pifferi ◽  
Benoit Laurent ◽  
Mélanie Plourde

Many prospective studies have shown that a diet enriched in omega-3 polyunsaturated fatty acids (n-3 PUFAs) can improve cognitive function during normal aging and prevent the development of neurocognitive diseases. However, researchers have not elucidated how n-3 PUFAs are transferred from the blood to the brain or how they relate to cognitive scores. Transport into and out of the central nervous system depends on two main sets of barriers: the blood-brain barrier (BBB) between peripheral blood and brain tissue and the blood-cerebrospinal fluid (CSF) barrier (BCSFB) between the blood and the CSF. In this review, the current knowledge of how lipids cross these barriers to reach the CNS is presented and discussed. Implications of these processes in health and disease, particularly during aging and neurodegenerative diseases, are also addressed. An assessment provided here is that the current knowledge of how lipids cross these barriers in humans is limited, which hence potentially restrains our capacity to intervene in and prevent neurodegenerative diseases.


Eye ◽  
1990 ◽  
Vol 4 (2) ◽  
pp. 249-254 ◽  
Author(s):  
M W B Bradbury ◽  
S L Lightman
Keyword(s):  

1994 ◽  
Vol 277 (1) ◽  
pp. 87-95 ◽  
Author(s):  
Jyh-Lyh Juang ◽  
Stanley D. Carlson

2007 ◽  
pp. 601-618
Author(s):  
Pedro M. Faustmann ◽  
Claus G. Haase

2015 ◽  
Vol 23 ◽  
pp. S142
Author(s):  
Hironori Okada ◽  
Hidetoshi Ishibashi ◽  
Chiaki Masuda ◽  
Hiromi Hayashita-Kinoh ◽  
Tomoko Chiyo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document